Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-11-07

Clinical Trial Update: Incidence and Clinical Burden of Erythropoietin Hyporesponsiveness - a Retrospective Database Analysis

View source ↗

Summary

A retrospective database analysis assesses how frequently erythropoietin hyporesponsiveness occurs in chronic kidney disease and the associated clinical burden.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Astellas Pharma Global Development, Inc. | Conditions: Chronic Kidney Disease | Status: COMPLETED